NASDAQ:BNFT - Benefitfocus Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $14.00
  • Forecasted Upside: 0.57 %
  • Number of Analysts: 4
  • Breakdown:
  • 1 Sell Ratings
  • 2 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$13.92
▼ -0.35 (-2.45%)
1 month | 3 months | 12 months
Get New Benefitfocus Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BNFT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BNFT

Average Price Target: $14.00
▲ +0.57% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Benefitfocus in the last 3 months. The average price target is $14.00, with a high forecast of $17.00 and a low forecast of $12.00. The average price target represents a 0.57% upside from the last price of $13.92.

Hold

The current consensus among 4 polled investment analysts is to hold stock in Benefitfocus. This rating has held steady since April 2021, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 3 buy ratings
  • 6 hold ratings
  • 1 sell ratings
12/25/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings
3/24/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings
6/22/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
9/20/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
12/19/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/19/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/18/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 1 sell ratings
6/17/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/3/2021The Goldman Sachs GroupDowngradeNeutral ➝ Sell$13.00High
5/5/2021Piper SandlerBoost Price TargetOverweight$16.00 ➝ $17.00High
3/9/2021Piper SandlerLower Price TargetOverweight$20.00 ➝ $16.00High
1/27/2021Piper SandlerLower Price TargetOverweight$29.00 ➝ $20.00High
1/21/2021Raymond JamesDowngradeOutperform ➝ Market PerformHigh
11/6/2020Cantor FitzgeraldDowngradeOverweight ➝ Neutral$20.00 ➝ $12.00High
8/24/2020Raymond JamesReiterated RatingBuyHigh
8/6/2020Piper SandlerBoost Price TargetOverweight$26.00 ➝ $30.00High
6/29/2020The Goldman Sachs GroupBoost Price Target$11.00 ➝ $12.00Medium
5/7/2020Piper SandlerLower Price Target$35.00 ➝ $26.00Low
5/7/2020Wells Fargo & CompanyLower Price TargetOverweight$29.00 ➝ $25.00Medium
4/2/2020Cantor FitzgeraldReiterated RatingBuyMedium
3/4/2020Wells Fargo & CompanyLower Price TargetOverweight$40.00 ➝ $29.00High
3/4/2020Piper SandlerLower Price TargetOverweight$53.00 ➝ $35.00High
3/4/2020Raymond JamesLower Price TargetOutperform$25.00 ➝ $16.00High
3/4/2020Cantor FitzgeraldLower Price TargetOverweight$47.00 ➝ $25.00Medium
2/3/2020Royal Bank of CanadaReiterated RatingHold$45.00Medium
1/29/2020Raymond JamesLower Price TargetOutperform$30.00 ➝ $25.00High
1/8/2020Wells Fargo & CompanyLower Price TargetOverweight$42.00 ➝ $40.00Low
11/4/2019Compass PointInitiated CoverageBuy$37.00High
8/22/2019Chardan CapitalReiterated RatingHold$27.00High
8/8/2019Royal Bank of CanadaReiterated RatingHold$46.00Medium
8/7/2019Wells Fargo & CompanyReiterated RatingBuyHigh
8/7/2019Raymond JamesSet Price TargetOutperform$50.00 ➝ $30.00High
8/7/2019WedbushReiterated RatingBuy$40.00High
8/7/2019Cantor FitzgeraldLower Price TargetOverweight$60.00 ➝ $47.00High
7/29/2019WedbushLower Price TargetOutperform$52.00 ➝ $40.00Medium
7/3/2019JPMorgan Chase & Co.Initiated CoverageNeutral$32.00Low
5/2/2019Wells Fargo & CompanyLower Price TargetOutperform$60.00 ➝ $55.00High
5/1/2019Cantor FitzgeraldReiterated RatingBuy$60.00High
5/1/2019Royal Bank of CanadaLower Price TargetAverage ➝ Sector Perform$49.00Low
4/2/2019Cantor FitzgeraldInitiated CoverageOverweight$60.00 ➝ $60.00Low
2/27/2019Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$58.00Medium
2/27/2019Jefferies Financial GroupDowngradeBuy ➝ Hold$48.00 ➝ $55.00Medium
2/1/2019The Goldman Sachs GroupReiterated RatingNeutral ➝ Neutral$55.00Medium
12/19/2018WedbushReiterated RatingBuy$57.00High
12/19/2018Royal Bank of CanadaBoost Price TargetOutperform ➝ Average$58.00Low
12/19/2018Wells Fargo & CompanyBoost Price TargetOutperform ➝ Outperform$50.00 ➝ $60.00Low
12/11/2018Piper Jaffray CompaniesReiterated RatingOverweight ➝ Positive$61.00High
12/4/2018WedbushBoost Price TargetOutperform ➝ Outperform$44.00 ➝ $57.00Medium
11/30/2018Raymond JamesBoost Price TargetOutperform ➝ Outperform$50.00 ➝ $58.00High
11/2/2018WedbushBoost Price TargetOutperform ➝ Outperform$42.00 ➝ $44.00N/A
11/2/2018Piper Jaffray CompaniesReiterated RatingOverweight$49.00High
11/2/2018Jefferies Financial GroupBoost Price TargetBuy$48.00High
10/18/2018WedbushInitiated CoverageOutperform ➝ Outperform$42.00Low
8/24/2018Raymond JamesBoost Price TargetOutperform ➝ Outperform$40.00 ➝ $50.00High
8/20/2018GuggenheimInitiated CoverageBuy$45.00High
8/3/2018Chardan CapitalBoost Price TargetNeutral$34.00 ➝ $36.00Medium
7/20/2018Jefferies Financial GroupReiterated RatingBuy$43.00Low
6/29/2018Piper Jaffray CompaniesBoost Price TargetOverweight$40.00Low
5/16/2018Wells Fargo & CompanySet Price TargetBuy$30.00 ➝ $38.00Low
5/4/2018Berenberg BankSet Price TargetBuy$35.00High
5/4/2018Chardan CapitalBoost Price TargetNeutral ➝ Neutral$27.00 ➝ $34.00High
5/4/2018Jefferies Financial GroupBoost Price TargetBuy$35.00High
5/4/2018Royal Bank of CanadaUpgradeSector Perform ➝ OutperformHigh
3/22/2018Jefferies Financial GroupReiterated RatingBuy$31.00Low
3/15/2018Berenberg BankSet Price TargetBuy$29.00High
3/15/2018Wells Fargo & CompanyReiterated RatingBuy$35.00 ➝ $30.00High
3/15/2018Royal Bank of CanadaLower Price TargetSector Perform$24.00High
3/15/2018Chardan CapitalLower Price TargetNeutral ➝ Neutral$28.00 ➝ $27.00High
3/15/2018Canaccord GenuityReiterated RatingBuy ➝ Buy$32.00 ➝ $29.00High
3/15/2018Jefferies Financial GroupLower Price TargetBuy$30.00High
11/3/2017Piper Jaffray CompaniesReiterated RatingBuy$34.00N/A
11/3/2017William BlairDowngradeOutperform ➝ Market PerformN/A
10/30/2017Canaccord GenuityReiterated RatingBuy$34.00N/A
8/10/2017Berenberg BankReiterated RatingBuy$36.00Low
8/4/2017Piper Jaffray CompaniesReiterated RatingBuy$43.00High
8/4/2017Chardan CapitalDowngradeBuy ➝ Neutral$36.00 ➝ $30.00High
8/1/2017Canaccord GenuityReiterated RatingBuy$35.00Low
7/27/2017Raymond JamesBoost Price TargetOutperform$38.00 ➝ $43.00Low
6/1/2017William BlairUpgradeMarket Perform ➝ OutperformHigh
4/28/2017Chardan CapitalBoost Price TargetBuy ➝ Buy$31.00 ➝ $36.00High
3/16/2017Canaccord GenuityReiterated RatingBuy$33.00Low
3/16/2017Jefferies Financial GroupReiterated RatingBuy$35.00High
3/15/2017Chardan CapitalReiterated RatingBuy$31.00Medium
2/24/2017Royal Bank of CanadaReiterated RatingHold$33.00N/A
2/24/2017Jefferies Financial GroupLower Price TargetBuy$41.00 ➝ $35.00N/A
2/22/2017Canaccord GenuityReiterated RatingBuy$35.00N/A
2/7/2017Berenberg BankInitiated CoverageBuy$36.00N/A
1/6/2017Chardan CapitalInitiated CoverageBuy$36.00N/A
11/4/2016Deutsche Bank AktiengesellschaftReiterated RatingBuy$45.00 ➝ $65.00N/A
11/4/2016Raymond JamesReiterated RatingStrong-Buy ➝ Outperform$56.00 ➝ $34.00N/A
11/4/2016UBS GroupDowngradeStrong-Buy ➝ OutperformN/A
11/1/2016Jefferies Financial GroupReiterated RatingBuy$50.00N/A
8/12/2016Jefferies Financial GroupBoost Price TargetBuy$45.00 ➝ $50.00N/A
8/5/2016Canaccord GenuityReiterated RatingBuy$48.00N/A
8/4/2016Jefferies Financial GroupBoost Price TargetBuy$43.00 ➝ $45.00N/A
8/4/2016Deutsche Bank AktiengesellschaftBoost Price TargetBuy$60.00 ➝ $65.00N/A
8/1/2016Royal Bank of CanadaReiterated RatingSector Perform$36.00 ➝ $46.00N/A
8/1/2016Royal Bank of CanadaBoost Price TargetSector Perform$36.00 ➝ $46.00N/A
(Data available from 6/18/2016 forward)
Benefitfocus logo
Benefitfocus, Inc. provides cloud-based benefits management technology solutions for employers and health plans in the United States. Its products for employers comprise Benefitplace, a cloud-based benefits management portal that streamlines online enrollment, employee communication, and benefit administration; Health Insights, a data analytics solution; ACA Management and Reporting, a solution for employers to manage ACA compliance; Billing & Payments, an application that synchronizes enrollment and billing information to streamline the monthly billing process, automate adjustments, and enhance accuracy of payments; and COBRA Administration, a solution that simplifies management of Consolidated Omnibus Budget Reconciliation Act, benefits. The company's products for health plans include Enrollment that provides platform for carriers to automate enrollment across all segments of their commercial group business; Billing & Payments, an electronic invoice presentment and payment solution; Exchange, a solution that bridges the integration gap between health plan and employer systems; and Quoting that gives health plans and brokers tools to organize and proactively manage accounts, track leads, generate quotes, and create proposals for multiple products. Its products for brokers consist of Health Insights that support strategic decisions for their clients with on-demand health plan analytics; Benefit Catalog, which allows brokers to offer products to their clients; and benefit catalog consultative support for brokers through benefit advisors. The company also provides implementation services to its customers in order to help ensure seamless deployment and effective utilization of its solutions; and employers with expanded support services. The company was incorporated in 2000 and is headquartered in Charleston, South Carolina.
Read More

Today's Range

Now: $13.92
Low: $13.86
High: $14.37

50 Day Range

MA: $14.09
Low: $13.47
High: $14.79

52 Week Range

Now: $13.92
Low: $9.36
High: $17.58

Volume

409,283 shs

Average Volume

326,734 shs

Market Capitalization

$461.88 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.75

Frequently Asked Questions

What sell-side analysts currently cover shares of Benefitfocus?

The following Wall Street research analysts have issued reports on Benefitfocus in the last year: Cantor Fitzgerald, Piper Sandler, Raymond James, The Goldman Sachs Group, Inc., TheStreet, and Zacks Investment Research.
View the latest analyst ratings for BNFT.

What is the current price target for Benefitfocus?

3 Wall Street analysts have set twelve-month price targets for Benefitfocus in the last year. Their average twelve-month price target is $14.00, suggesting a possible upside of 0.6%. Piper Sandler has the highest price target set, predicting BNFT will reach $17.00 in the next twelve months. Cantor Fitzgerald has the lowest price target set, forecasting a price of $12.00 for Benefitfocus in the next year.
View the latest price targets for BNFT.

What is the current consensus analyst rating for Benefitfocus?

Benefitfocus currently has 1 sell rating, 2 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in BNFT, but not buy more shares or sell existing shares.
View the latest ratings for BNFT.

What other companies compete with Benefitfocus?

How do I contact Benefitfocus' investor relations team?

Benefitfocus' physical mailing address is 100 BENEFITFOCUS WAY, CHARLESTON SC, 29492. The software maker's listed phone number is 843-849-7476 and its investor relations email address is [email protected] The official website for Benefitfocus is www.benefitfocus.com.